Atlas FDA

LINX REFLUX MANAGEMENT SYSTEM

FDA premarket approval P100049/S002 · decided 2012-06-22

Approval details

PMA number
P100049
Supplement
S002
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
LINX REFLUX MANAGEMENT SYSTEM
Generic name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Applicant
Torax Medical
Date received
2012-04-23
Decision date
2012-06-22
Days to decision
60 days
Decision code
APPR
Product code
LEI
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Cincinnati, OH
Statement
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.